Search for: "Lisa Ouellette"
Results 121 - 140
of 166
Sorted by Relevance
|
Sort by Date
3 Mar 2022, 6:43 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]
30 Oct 2020, 12:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
22 Mar 2017, 4:42 am
” In a Wall Street Journal op-ed, Daniel Hamel and Lisa Larrimore Ouellette maintain that the case is essentially “about price discrimination, the practice of charging higher prices to customers who likely can pay more and offering discounts to those who cannot,” and they urge the justices to “consider what their decision might mean for consumers beyond the U.S. [read post]
1 Feb 2022, 6:48 am
Durvasula, Lisa Larrimore Ouellette, and Heidi L. [read post]
1 May 2018, 4:37 am
Lisa Ouellette has astutely observed that the importance of agency-head final decision-making authority merits further theoretical development and empirical investigation. [read post]
21 Jan 2015, 2:46 am
Commentary comes from Lisa Larrimore Ouellette at Written Description. [read post]
27 Mar 2017, 4:18 am
At Written Description, Lisa Ouellette offers some “thoughts on the policy tradeoffs” at play in Impression Products, Inc. v. [read post]
9 Sep 2012, 4:24 pm
Sawicki, Assistant Professor, Loyola Chicago School of Law; 2003-2009, George Sharswood Fellow in Law and Bioethics, University of Pennsylvania Law School Lisa Comeau, Esq., appellate counsel for the patient’s family in Cronin v. [read post]
6 Feb 2015, 6:00 am
Lisa Larrimore Ouellette (Stanford) (@PatentScholar) has created a Twitter list that makes it easier to follow all of the professors listed in the census. [read post]
6 Jan 2015, 6:46 pm
Thomas Anthony Niedwiecki LawProfAnt John Marshall (Chicago) Sean Nolon snolon Vermont Tracy Norton millennialprof Touro Tracy Norton profnorton Touro Beth Simone Noveck bethnoveck NYLS Rory O'Connell rjjoconnell Queens University Belfast Shuyi Oei ShuyiOei Tulane Paul Ohm paulohm Colorado David Opderbeck dopderbeck Seton Hall Lisa Ouellette PatentScholar Stanford Kevin Outterson koutterson Boston University Jessica Owley JessicaOwley Buffalo Frank Pasquale FrankPasquale Seton… [read post]
20 May 2020, 1:58 pm
Guest Post by Colleen V. [read post]
19 May 2020, 3:30 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsLast week, we focused on incentives for developing clinical evidence supporting the use of remdesivir for COVID-19 and analyzed the FDA’s grant of an emergency use authorization (EUA) for the drug. [read post]
27 Sep 2021, 7:26 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsHistorically, the United States’ preparedness for a pandemic is like Charles Dudley Warner’s aphorism on the weather: everybody talks about it but no one ever does anything. [read post]
2 Oct 2020, 7:10 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn recent weeks, a number of articles have reported great concern around the politicization of the approval process for future COVID-19 vaccines. [read post]
24 Jun 2020, 5:36 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
18 Jun 2020, 1:23 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsIn the United States, one of the most important factors in receiving COVID-19 testing or treatment is access to insurance. [read post]
9 Mar 2018, 12:54 pm
To give one example, in their recent article, Bayh-Dole Without Borders, Lisa Larrimore Ouellette and Daniel Hemel observe that an under-appreciated feature of making federal funding for research work as an economic policy is ensuring that U.S. companies are able to protect the results of that federally-funded research abroad. [read post]
21 Jan 2022, 8:35 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe FDA has now authorized three vaccines and several treatments (including both monoclonal antibodies and small-molecule drugs) for the prevention and treatment of COVID-19. [read post]
21 Apr 2020, 2:09 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOur recent posts have highlighted shortages in three COVID-19-related knowledge goods: testing, drugs (such as those needed to put patients on ventilators), and clinical trial information about effective treatments. [read post]
8 Jun 2022, 5:23 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
